Seres Therapeutics, Inc.

MCRB

$3.52

Name : Seres Therapeutics, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $35,357,628.00

EPSttm : -2.42

Seres Therapeutics, Inc.

$3.52

2.76%

$0.1

MCRB — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

Margin Of Safety %

Put/Call OI Ratio

0.4

EPS Next Q Diff

0.49

EPS Last/This Y

-4.16

EPS This/Next Y

-1.43

Price

3.52

Target Price

Analyst Recom

Performance Q

-50.28

Upside

-942.0%

Beta

0.29

Ticker: MCRB

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-08-28	MCRB	5.09	0.42	0.00	4597
2026-08-31	MCRB	4.93	0.42	0.00	4597
2026-09-02	MCRB	5.52	0.42	0.05	4588
2026-09-03	MCRB	5.77	0.42	0.00	4604
2026-09-04	MCRB	5.71	0.42	0.50	4626
2026-09-08	MCRB	5.61	0.42	0.00	4627
2026-09-09	MCRB	5.36	0.41	0.00	4674
2026-09-10	MCRB	5.14	0.41	0.00	4674
2026-09-11	MCRB	5.04	0.41	0.00	4674
2026-09-14	MCRB	4.74	0.41	0.00	4674
2026-09-15	MCRB	4.62	0.41	0.00	4674
2026-09-16	MCRB	4.18	0.41	0.00	4675
2026-09-17	MCRB	4.11	0.41	0.06	4676
2026-09-18	MCRB	4	0.40	0.02	4697
2026-09-21	MCRB	4.02	0.41	25.00	4659
2026-09-22	MCRB	4.04	0.41	25.00	4659
2026-09-23	MCRB	3.7865	0.41	0.00	4661
2026-09-24	MCRB	3.63	0.41	0.06	4664
2026-09-25	MCRB	3.53	0.40	0.00	4765
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-08-28	MCRB	5.09	-100.0	-96.5	-3.52
2026-08-31	MCRB	4.93	-100.0	-94.8	-3.52
2026-09-01	MCRB	5.18	-100.0	-98.0	-3.52
2026-09-02	MCRB	5.51	-100.0	-101.4	-3.52
2026-09-03	MCRB	5.73	-100.0	-99.7	-3.52
2026-09-04	MCRB	5.67	-100.0	-97.7	-3.52
2026-09-08	MCRB	5.54	-100.0	-96.9	-3.52
2026-09-09	MCRB	5.34	-100.0	-96.3	-3.52
2026-09-10	MCRB	5.09	-100.0	-97.1	-3.52
2026-09-11	MCRB	5.04	-100.0	-98.1	-3.52
2026-09-14	MCRB	4.75	-100.0	-96.1	-3.52
2026-09-15	MCRB	4.62	-100.0	-97.3	-3.52
2026-09-16	MCRB	4.62	-100.0	-97.3	-3.52
2026-09-17	MCRB	4.11	-100.0	-97.0	-3.52
2026-09-18	MCRB	4.02	-100.0	-97.6	-3.52
2026-09-21	MCRB	4.07	-100.0	-99.2	-3.52
2026-09-22	MCRB	4.02	-100.0	-98.7	-3.52
2026-09-23	MCRB	3.79	-100.0	-95.9	-3.52
2026-09-24	MCRB	3.64	-100.0	-97.2	-3.52
2026-09-25	MCRB	3.52	-100.0	-97.3	-3.52
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-08-28	MCRB	-0.04	-0.41	4.89
2026-08-31	MCRB	-0.04	-0.41	4.89
2026-09-01	MCRB	-0.04	-0.41	4.89
2026-09-02	MCRB	-0.04	-0.41	4.89
2026-09-03	MCRB	-0.04	-0.41	4.89
2026-09-04	MCRB	-0.04	-0.41	4.89
2026-09-08	MCRB	-0.04	-0.41	4.89
2026-09-09	MCRB	-0.04	-0.41	4.89
2026-09-10	MCRB	-0.04	-0.41	4.89
2026-09-11	MCRB	-0.04	-0.41	4.73
2026-09-14	MCRB	-0.04	-0.39	4.73
2026-09-15	MCRB	-0.04	-0.39	4.73
2026-09-16	MCRB	-0.04	-0.39	4.73
2026-09-17	MCRB	-0.04	-0.39	4.73
2026-09-18	MCRB	-0.04	-0.39	4.73
2026-09-21	MCRB	-0.04	-0.39	4.73
2026-09-23	MCRB	-0.04	-0.39	4.73
2026-09-24	MCRB	-0.04	-0.39	4.73
2026-09-25	MCRB	-0.04	-0.39	4.00
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-1.5

Avg. EPS Est. Current Quarter

-1

Avg. EPS Est. Next Quarter

-1.01

Insider Transactions

-0.04

Institutional Transactions

-0.39

Beta

0.29

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

98.5

Max Drawdown 5-Year %

-98.4

Target Price

P/E

Forward P/E

PEG

P/S

18.61

P/B

P/Free Cash Flow

EPS

-2.28

Average EPS Est. Cur. Y

-3.52

EPS Next Y. (Est.)

-4.95

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-1192.94

Relative Volume

0.69

Return on Equity vs Sector %

-91.3

Return on Equity vs Industry %

-71.7

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

-97.3

◆ MCRB Healthcare

$3.52

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

15/25

Volume

9/15

Valuation

12/20

TP/AR

2/10

Options

7/10

RSI

26.6

Range 1M

0.4%

Sup Dist

1.1%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

14/25

Growth

12/30

Estimates

0/20

Inst/Vol

0/15

Options

7/10

EPS Yr

-649.1%

EPS NY

-40.7%

52W%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +383% upside

Quality

2/30

Valuation

16/30

Growth

7/25

Stability

3/10

LT Trend

4/5

Upside

+383%

Quality

MCRB — P/E HistoricalBiotechnology

Seres Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 66

Seres Therapeutics, Inc., a clinical-stage company, focuses on developing biotherapeutics for serious diseases. The company develops SER-155, an investigational oral live biotherapeutic to decolonize GI pathogens, enhance GI epithelial barrier integrity, and regulate immune response to prevent bacterial bloodstream infections, as well as other pathogen-associated negative clinical outcomes in patients undergoing allogeneic hematopoietic stem cell transplantation. It also develops SER-603, a LBP candidate optimized to treat disruptions in the GI microbiome and to improve GI mucosal barrier integrity through the inhibition of inflammatory bacteria and associated metabolites; and SER-147, a live biotherapeutic composition to prevent bacterial bloodstream and spontaneous bacterial peritonitis infections in patients with metabolic disease, including chronic liver disease. The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.

MCRB

Latest News

—

Caricamento notizie per MCRB…

stock quote shares MCRB – Seres Therapeutics, Inc. Stock Price stock today

news today MCRB – Seres Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch MCRB – Seres Therapeutics, Inc. yahoo finance google finance

stock history MCRB – Seres Therapeutics, Inc. invest stock market

stock prices MCRB premarket after hours

ticker MCRB fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: MCRB

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y